BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9882290)

  • 21. Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
    Jansson M; Backström E; Scarlatti G; Björndal A; Matsuda S; Rossi P; Albert J; Wigzell H
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1405-14. PubMed ID: 11679153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.
    Dittmar MT; Simmons G; Donaldson Y; Simmonds P; Clapham PR; Schulz TF; Weiss RA
    J Virol; 1997 Jul; 71(7):5140-7. PubMed ID: 9188581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
    Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.
    Gorry PR; Taylor J; Holm GH; Mehle A; Morgan T; Cayabyab M; Farzan M; Wang H; Bell JE; Kunstman K; Moore JP; Wolinsky SM; Gabuzda D
    J Virol; 2002 Jun; 76(12):6277-92. PubMed ID: 12021361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the env gene of human immunodeficiency virus type 1 NDK isolates and the use of African green monkey CXCR4 as a co-receptor in COS-7 cells.
    Dumonceaux J; Chanel C; Valente S; Quivet L; Briand P; Hazan U
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1975-1982. PubMed ID: 10466793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary CCR5 only using HIV-1 isolates does not accurately represent the in vivo replicating quasi-species.
    Aasa-Chapman MM; Aubin K; Williams I; McKnight A
    Virology; 2006 Aug; 351(2):489-96. PubMed ID: 16712896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
    Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E
    J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.
    Ohagen A; Devitt A; Kunstman KJ; Gorry PR; Rose PP; Korber B; Taylor J; Levy R; Murphy RL; Wolinsky SM; Gabuzda D
    J Virol; 2003 Nov; 77(22):12336-45. PubMed ID: 14581570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.
    Albright AV; Shieh JT; Itoh T; Lee B; Pleasure D; O'Connor MJ; Doms RW; González-Scarano F
    J Virol; 1999 Jan; 73(1):205-13. PubMed ID: 9847323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.
    Worgall S; Connor R; Kaner RJ; Fenamore E; Sheridan K; Singh R; Crystal RG
    J Virol; 1999 Jul; 73(7):5865-74. PubMed ID: 10364338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.
    Sullivan N; Sun Y; Binley J; Lee J; Barbas CF; Parren PW; Burton DR; Sodroski J
    J Virol; 1998 Aug; 72(8):6332-8. PubMed ID: 9658072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.
    Lee B; Doranz BJ; Rana S; Yi Y; Mellado M; Frade JM; Martinez-A C; O'Brien SJ; Dean M; Collman RG; Doms RW
    J Virol; 1998 Sep; 72(9):7450-8. PubMed ID: 9696841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
    Johnston JB; Power C
    J Virol; 2002 Apr; 76(8):3626-36. PubMed ID: 11907202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4.
    Xiao P; Usami O; Suzuki Y; Ling H; Shimizu N; Hoshino H; Zhuang M; Ashino Y; Gu H; Hattori T
    AIDS; 2008 Sep; 22(14):1749-57. PubMed ID: 18753859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.